会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 43. 发明授权
    • Mammalian melanocortin receptors and uses
    • 哺乳动物黑皮质素受体和用途
    • US5994087A
    • 1999-11-30
    • US475637
    • 1995-06-07
    • Roger D. ConeLinda Roselli-RehfussKathleen G. MountjoyLinda S. Robbins
    • Roger D. ConeLinda Roselli-RehfussKathleen G. MountjoyLinda S. Robbins
    • C07K14/72C12N15/12G01N33/74G01N33/567G01N33/48G01N33/53G01N33/574
    • G01N33/74C07K14/723
    • The present invention relates to a mammalian melanocortin receptor. The invention is directed toward the isolation, characterization and pharmacological use of a mammalian melanocortin receptor (MC3-R). The invention specifically provides a particular melanocortin receptor, termed MC3-R, isolated as a complementary DNA copy of mRNA corresponding to the gene for this receptor in rats. Also provided is a eukaryotic recombinant expression construct capable of expressing a mammalian melanocortin receptor in cultures of transformed eukaryotic cells and such cultures of transformed eukaryotic cells that synthesize a mammalian melanocortin receptor. The invention also provides methods for screening in vitro agonists and antagonists of such a melanocortin receptor using preparations of receptor protein from such cultures of eukaryotic cells transformed with a recombinant expression construct.
    • 本发明涉及哺乳动物黑皮质素受体。 本发明涉及哺乳动物黑皮质素受体(MC3-R)的分离,表征和药理学应用。 本发明特别提供了一种称为MC3-R的特异性黑皮质素受体,其被分离为相应于大鼠该受体基因的mRNA的互补DNA拷贝。 还提供了能够在转化的真核细胞和合成哺乳动物黑皮质素受体的转化真核细胞的这种培养物中表达哺乳动物黑皮质素受体的真核重组表达构建体。 本发明还提供了使用来自用重组表达构建体转化的真核细胞的这种培养物的受体蛋白质的制备物筛选这种黑皮质素受体的体外激动剂和拮抗剂的方法。
    • 44. 发明授权
    • Excitatory amino acid transporter gene and uses
    • 兴奋性氨基酸转运蛋白基因及用途
    • US5882926A
    • 1999-03-16
    • US948569
    • 1997-10-10
    • Susan G. AmaraJeffrey L. ArrizaScott EliasofMichael P. Kavanaugh
    • Susan G. AmaraJeffrey L. ArrizaScott EliasofMichael P. Kavanaugh
    • A61K38/00C07K14/47C12N5/00C07H21/04C07K1/00C12N15/00
    • C07K14/47A61K38/00C07K2319/00C12N2799/023
    • This invention relates to novel mammalian excitatory amino acid transporter proteins and genes encoding such proteins. The invention is directed towards the isolation, characterization and use of human excitatory amino acid transporter proteins for pharmacological screening of analogues, agonists, antagonists, inhibitors, modulators and facilitators of excitatory amino acid transport in a variety of tissues, particularly neuronal tissues. This invention provides isolated nucleic acid encoding a novel excitatory amino acid transporter subtype that is specifically expressed in retina. Also provided are recombinant expression constructs capable of expressing this novel transporter in transformed prokaryotic and eukaryotic cells, and also provides such transformed cell cultures producing the novel human transporter. Purified transporter protein and membranes comprising the transporter protein are also provided. The invention provides methods of screening compounds in vitro for transporter binding properties using said preparations of protein and membranes from transformed cell cultures, as well as from amphibian oocytes expressing the human transporter protein provided herein.
    • 本发明涉及新型的哺乳动物兴奋性氨基酸转运蛋白和编码这种蛋白质的基因。 本发明涉及人类兴奋性氨基酸转运蛋白的分离,表征和用途,用于药物筛选各种组织,特别是神经元组织中兴奋性氨基酸转运的类似物,激动剂,拮抗剂,抑制剂,调节剂和促进剂。 本发明提供编码在视网膜中特异性表达的新型兴奋性氨基酸转运子亚型的分离的核酸。 还提供了能够在转化的原核和真核细胞中表达该新型转运蛋白的重组表达构建体,并且还提供产生新型人转运蛋白的转化细胞培养物。 还提供了纯化的转运蛋白和包含转运蛋白的膜。 本发明提供了使用所述来自转化细胞培养物的蛋白质和膜的制备以及来自表达本文提供的人类转运蛋白的两栖动物卵母细胞的体外筛选化合物的转运蛋白结合特性的方法。
    • 48. 发明授权
    • Bacterial hemoglobin receptor gene
    • 细菌血红蛋白受体基因
    • US5698438A
    • 1997-12-16
    • US326670
    • 1994-10-18
    • Igor StojiljkovicMagdalene SoVivian HwaFred HeffronXavier Nassif
    • Igor StojiljkovicMagdalene SoVivian HwaFred HeffronXavier Nassif
    • A61K38/00A61K39/00C07K14/22C12N1/21C12N15/31C12N15/74
    • C07K14/22A61K38/00A61K39/00Y10S530/825
    • The present invention relates to a novel bacterial hemoglobin receptor protein and genes that encode such a protein. The invention is directed toward the isolation, characterization, diagnostic and therapeutic use of a bacterial hemoglobin receptor protein, nucleic acid encoding such a protein, recombinant expression constructs comprising such nucleic acids and cells transformed therewith, and antibodies and epitopes of such hemoglobin receptor proteins. The invention relates particularly to hemoglobin receptor proteins and genes encoding such proteins from Neisseria species, especially N. meningitidis. Methods for the diagnostic and therapeutic use of the proteins, epitopes, antibodies and nucleic acids of the invention are also provided, including the use of the proteins, epitopes, antibodies and nucleic acids of the invention for the production of vaccines effective in providing immunization of a human against infection by pathogenic bacteria of Neisseria species.
    • 本发明涉及一种新的细菌性血红蛋白受体蛋白质和编码这种蛋白质的基因。 本发明涉及细菌血红蛋白受体蛋白的分离,表征,诊断和治疗用途,编码这种蛋白质的核酸,包含这种核酸的重组表达构建体和与其转化的细胞,以及这些血红蛋白受体蛋白的抗体和表位。 本发明特别涉及血红蛋白受体蛋白和编码奈瑟氏球菌(Neisseria),特别是脑膜炎奈瑟氏菌(N脑膜炎奈瑟氏球菌)的蛋白质的基因。 还提供了本发明的蛋白质,表位,抗体和核酸的诊断和治疗用途的方法,包括使用本发明的蛋白质,表位,抗体和核酸来生产有效提供免疫的疫苗 一种人抵抗奈瑟氏球菌病原菌的感染。